Endo-Q: Dialysis and Mediterranean Diet bit.ly/3LGB7Xc

Endo-Q: Infant Microbiome and T1D Risk bit.ly/3pVLgaU

Endocrinology News Highlights, May 2023 bit.ly/3oPWNIJ

ENDO 2023 Meeting Preview bit.ly/45PVEl4

📢 Recent research unveils unaddressed patient risks: 1️⃣ Transgender adolescent menstruation 2️⃣ Testosterone use in transgender men 3️⃣ Breast cancer screening in trans & gender diverse Patient well-being matters! #Healthcare #TransHealth #Safety bit.ly/3CgkMFd

Emotional Health and Diabetes bit.ly/3X7eK2r

Endocrinology News Highlights, June 2023 bit.ly/3JjAdiD

Skin Symptoms Linked to Endocrine Conditions bit.ly/3PrBXKT

Endo-Q: Trends in Incidence and Prevalence of PCOS in the US bit.ly/3JRjJ1R

Endo-Q: Endocrine-Disrupting Chemicals Linked to Weight Gain bit.ly/46mGTGV

ENDO 2023: Optimizing Glycemic Control bit.ly/3O4dSbC

Endo-Q: At-Home Kidney Function Testing bit.ly/43zXGn5

Endocrinology News Highlights, July 2023 bit.ly/44UCPvV

Endocrinology News Highlights, August 2023 bit.ly/3OVCCSP

Endo-Q: Racial Discrimination and Pediatric Obesity bit.ly/3ZvUEjm

Endocrinology News Highlights, September 2023 bit.ly/467k0Xh

Tarcocimab tedromer showed positive results in improving #diabeticretinopathy in the GLOW study, achieving at least a two-step improvement in the DRSS score and reducing the risk of vision-threatening complications. bit.ly/47DY5ay #ophthamology #MedED #MedTwitter

The #casebreaks podcast can also now be found on MedCentral!

Follow MedCentral for continued coverage of endocrine disorders like #thyroideyedisease!